KC
RDHL

Kepos Capital’s Redhill Biopharma RDHL Stock Holding History

Kepos Capital’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-108
Closed -$656K – 284
2019
Q4 		$656K Hold
108
– – 0.06% 194
2019
Q3 		$760K Hold
108
– – 0.07% 148
2019
Q2 		$702K Hold
108
– – 0.07% 187
2019
Q1 		$897K Sell
108
-12
-10% -$94.9K 0.07% 217
2018
Q4 		$666K Sell
120
-99
-45% -$759K 0.05% 251
2018
Q3 		$1.93M Hold
219
– – 0.1% 165
2018
Q2 		$1.87M Buy
+219
New +$1.39M 0.1% 166

Other funds holding RDHL

II
Ibex Investors Denver, Colorado $194M AUM 23.58% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Kepos Capital's RDHL Position: Q1 2020 in Review

Kepos Capital sold out of Redhill Biopharma (RDHL) in Q1 2020, closing a stake of 108 shares — an estimated $656K sold.

Kepos Capital first reported a position in RDHL in Q2 2018 and held it in 7 quarters. The position peaked at $1.93M in Q3 2018. 46 funds tracked by Wall St. Rank hold RDHL as of Q1 2020.

  • Kepos Capital reported no remaining Redhill Biopharma position as of Q1 2020 after selling out during the quarter.
  • Kepos Capital sold 108 Redhill Biopharma shares in Q1 2020, an estimated $656K.
  • Kepos Capital first reported a position in Redhill Biopharma in Q2 2018 and held it in 7 quarters.
  • Kepos Capital's Redhill Biopharma position peaked at $1.93M in Q3 2018.
  • 46 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2020.

Based on Kepos Capital's 13F filing for Q1 2020, filed 12 May 2020.